These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest fell by 5 funds last quarter. Jeffrey Jay and David Kroin's fund, Great Point Partners, also sold off its stock, about $3.2 million worth. At the top of the heap, Ken Griffin's Citadel Investment Group dumped the largest investment of the 750 funds followed by Insider Monkey, comprising close to $6.4 million in stock. (NASDAQ:SBTX) has witnessed declining sentiment from hedge fund managers, it's safe to say that there lies a certain "tier" of fund managers that elected to cut their entire stakes last quarter. OrbiMed Advisors is also relatively very bullish on the stock, dishing out 3.57 percent of its 13F equity portfolio to SBTX. (NASDAQ:SBTX), around 4.9% of its 13F portfolio. In terms of the portfolio weights assigned to each position EcoR1 Capital allocated the biggest weight to Silverback Therapeutics, Inc. RA Capital Management, Nantahala Capital Management, and Cormorant Asset Management were also very fond of the stock, becoming one of the largest hedge fund holders of the company. On the second spot was EcoR1 Capital which amassed $110.5 million worth of shares. (NASDAQ:SBTX), which was worth $381.4 million at the end of the fourth quarter. Īmong these funds, OrbiMed Advisors held the most valuable stake in Silverback Therapeutics, Inc. You can download a sample issue of this newsletter on our website. Also, our monthly newsletter's portfolio of long stock picks returned 206.8% since March 2017 (through May 2021) and beat the S&P 500 Index by more than 115 percentage points. Insider Monkey's flagship short hedge fund strategy outstripped the S&P 500 short ETFs by around 20 percentage points annually since its inception in March 2017. These hedge fund managers administer most of the smart money's total asset base, and by following their matchless stock picks, Insider Monkey has unsheathed a number of investment strategies that have historically defeated Mr. While there are over 8000 funds trading at the moment, Our experts look at the moguls of this group, around 850 funds. To most traders, hedge funds are perceived as underperforming, old financial vehicles of years past. Our calculations also showed that SBTX isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings). The all time high for this statistic is 24. (NASDAQ: SBTX) was in 19 hedge funds' portfolios at the end of March. (NASDAQ: SBTX) has experienced a decrease in support from the world's most elite money managers recently. Is SBTX a good stock to buy? Silverback Therapeutics, Inc. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards Silverback Therapeutics, Inc. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. This article was published by S&P Global Market Intelligence and not by S&P Global Ratings, which is a separately managed division of S&P Global.The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st. The company closed a $15.4 million series B funding round in August 2019. * Human Interest Inc., a company that provides retirement plans to small and medium-sized businesses, closed a $40 million series C round led by Oberndorf Enterprises LLC, Crunchbase Daily reported. In April 2015, the company pulled in $4.3 million in a seed funding round. secured $50 million in a series B funding round from a group of investors including 01 Advisors, Dragoneer Investment Group LLC, Franklin Templeton, EPIQ Capital Group LLC, TechCrunch reported. The company earlier raised $45.0 million in a series C round in October 2018. Future Fund and Sonae IM also participated in the funding round, Crunchbase Daily reported. pulled in $60 million in its series D round led by Blue Cloud Ventures, Stereo Capital. * Security-operations-center-as-a-service company Arctic Wolf Networks Inc. The biopharmaceutical company also garnered commitments from existing investors including OrbiMed Advisors LLC, Bristol-Meyers Squibb and Alexandria Venture Investments LLC. Venture Partners, with Nextech Invest Ltd., Hunt Investment Group, Pontifax Venture Capital, Colt Ventures LP and NS Investment also participating, FinSMEs reported. obtained $78.5 million in a series B financing round led by U.S. This feature rounds up select venture capital news on a regular basis and highlights larger deal coverage already published.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |